MASIMO AMERICAS, INC.

Masimo Americas, Inc. specializes in the design, manufacturing, and delivery of advanced patient monitoring systems and disposable medical sensors, with a focus on pulse oximetry, capnography, and sedation monitoring technologies. Their core capabilities center on the development and integration of proprietary Masimo SET® signal processing algorithms with clinical-grade hardware platforms, including the Masimo Root® patient monitoring system. The company delivers FDA-cleared, CE-marked medical devices and consumables such as reusable and disposable SpO2 sensors, capnography modules, and integrated sedation assessment kits, ensuring continuous, real-time physiological data acquisition in critical care and perioperative environments. Technical expertise includes low-power wireless sensor networks, signal integrity under motion artifact conditions, and seamless interoperability with hospital information systems via open protocols like HL7 and IEEE 11073. The contractor maintains a consistent, long-term relationship with the Department of Veterans Affairs, providing mission-critical monitoring equipment and consumables to VA medical centers nationwide. Their work supports VA’s clinical infrastructure for post-operative recovery, intensive care units, and ambulatory surgical centers, with recurring procurements of both hardware platforms and disposable sensor kits tailored to veteran-specific care needs. Masimo Americas operates primarily under NAICS 339112, focusing on surgical and medical instrument manufacturing for acute and chronic care settings. The company is positioned as a specialized provider of evidence-based physiological monitoring solutions, serving hospitals and clinics requiring high-fidelity, low-noise patient data in dynamic clinical environments. As a Tier 2 manufacturing entity based in Irvine, California, Masimo Americas leverages its engineering and production capabilities to meet stringent FDA and ISO 13485 quality standards. While no formal government certifications are listed, the company’s product portfolio is fully compliant with U.S. medical device regulatory requirements and is routinely procured through federal supply schedules and VA blanket purchase agreements.